Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure–Activity Relationships
Filippo Erli, Elena Guerrieri, Tanila Ben Haddou, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 17, pp. 7579-7590
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

In vivo brain GPCR signaling elucidated by phosphoproteomics
Jeffrey J. Liu, Kirti Sharma, Luca Zangrandi, et al.
Science (2018) Vol. 360, Iss. 6395
Open Access | Times Cited: 117
Biased Opioid Ligands
Abdelfattah Faouzi, Balázs Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kendall L. Mores, Benjamin Cummins, Robert J. Cassell, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 101
Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Federica Santino, Luca Gentilucci
Molecules (2023) Vol. 28, Iss. 1, pp. 346-346
Open Access | Times Cited: 22
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor
Edin Muratspahić, Kristine Deibler, Jianming Han, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Strategies for DevelopingκOpioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects
Kelly F. Paton, Diana Vivian Atigari, Sophia Kaska, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 375, Iss. 2, pp. 332-348
Open Access | Times Cited: 45
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse
Md Imdadul H. Khan, Benjamin J. Sawyer, Nicholas S. Akins, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114785-114785
Open Access | Times Cited: 27
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses
Amelia Dunn, Brian Reed, Jose Erazo, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 8, pp. 3590-3600
Closed Access | Times Cited: 41
Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy
Thomas O. Schrader, Kym I. Lorrain, Didier Bagnol, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 685-698
Closed Access | Times Cited: 4
Structurally Related Kappa Opioid Receptor Agonists with Substantial Differential Signaling Bias: Neuroendocrine and Behavioral Effects in C57BL6 Mice
Amelia Dunn, Brian Reed, Catherine Guariglia, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 9, pp. 847-857
Open Access | Times Cited: 37
Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain
Edin Muratspahić, Nataša Tomašević, Johannes Koehbach, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 9042-9055
Open Access | Times Cited: 25
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects
Alexander R. French, Richard M. van Rijn
Pharmacological Research (2022) Vol. 177, pp. 106091-106091
Open Access | Times Cited: 18
Novel tertiary diarylethylamines as functionally selective agonists of the kappa opioid receptor
Thomas O. Schrader, Kym I. Lorrain, Matthew R. Nelli, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130111-130111
Closed Access
Opioid signaling and design of analgesics
Barnali Paul, Sashrik Sribhashyam, Susruta Majumdar
Progress in molecular biology and translational science (2022), pp. 153-176
Open Access | Times Cited: 14
Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor
Kristina Puls, Gerhard Wolber
Molecules (2023) Vol. 28, Iss. 2, pp. 718-718
Open Access | Times Cited: 7
Development of a Selective Peptide κ-Opioid Receptor Antagonist by Late-Stage Functionalization with Cysteine Staples
Edin Muratspahić, Andrew M. White, Cosmin I. Ciotu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 17, pp. 11843-11854
Open Access | Times Cited: 7
Total Synthesis and Biological Activity of (±)-Guignardin A, (±)-Palmarumycin B9, and Their Derivatives
Leichuan Xu, Haoyun Ma, Xinkun An, et al.
ACS Agricultural Science & Technology (2024) Vol. 4, Iss. 3, pp. 356-367
Closed Access | Times Cited: 2
Conorphin-66 produces peripherally restricted antinociception via the kappa-opioid receptor with limited side effects
Kangtai Xu, Mengna Zhang, Dan Chen, et al.
Neuropharmacology (2024) Vol. 261, pp. 110157-110157
Closed Access | Times Cited: 2
Endogenous opiates and behavior: 2017
Richard J. Bodnar
Peptides (2019) Vol. 124, pp. 170223-170223
Closed Access | Times Cited: 18
The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
Miao‐Jin Ji, Jiao Yang, Zhiqiang Gao, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 13
Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening
Kristina Puls, Aina-Leonor Olivé-Marti, Siriwat Hongnak, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13788-13801
Open Access | Times Cited: 1
In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
Roberta Lattanzi, Silvia Rief, Helmut Schmidhammer, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 12
In Vitro, In Vivo and In Silico Characterization of a Novel Kappa-Opioid Receptor Antagonist
Kristina Puls, Aina-Leonor Olivé-Marti, Szymon Pach, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 680-680
Open Access | Times Cited: 7
Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
Helmut Schmidhammer, Filippo Erli, Elena Guerrieri, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5092-5092
Open Access | Times Cited: 10
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands
Mariana Spetea, Helmut Schmidhammer
Handbook of experimental pharmacology (2021), pp. 163-195
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top